Country: New Zealand
Language: English
Source: Medsafe (Medicines Safety Authority)
Calcium chloride dihydrate 0.2684 mg/mL; Potassium chloride 0.4 mg/mL; Sodium chloride 6 mg/mL; Sodium lactate 3.33 mg/mL (Formed in process from Lactic acid + Sodium hydroxide)
Baxter Healthcare Ltd
Calcium chloride dihydrate 0.2684 mg/mL
Solution for infusion
Active: Calcium chloride dihydrate 0.2684 mg/mL Potassium chloride 0.4 mg/mL Sodium chloride 6 mg/mL Sodium lactate 3.33 mg/mL (Formed in process from Lactic acid + Sodium hydroxide) Excipient: Water for injection
Bag, plastic, Solu-pac, 500 mL
General sale
General sale
Baxter Healthcare Pty Ltd
Compound Sodium Lactate (Hartmanns) infusion solution is indicated as a source of water and electrolytes. It is also used in patients as a source of bicarbonate in the treatment of mild to moderate metabolic acidosis associated with dehydration or associated with potassium deficiency. This solution is indicated as a method of intravenous drug delivery, if the drugs are compatible with the solution
Package - Contents - Shelf Life: Bag, plastic, - 500 mL - 24 months from date of manufacture stored at or below 30°C - Bag, plastic, - 1000 mL - 24 months from date of manufacture stored at or below 30°C
1974-08-22
NEW ZEALAND DATA SHEET COMPOUND SODIUM LACTATE (HARTMANNS) Data Sheet 23 May 2019 Page 1 of 13 Baxter Healthcare Ltd 1 COMPOUND SODIUM LACTATE (HARTMANNS), (solution for infusion) 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Compound Sodium Lactate (Hartmanns) infusion solution Product Potassium chloride Sodium chloride Sodium lactate Calcium chloride dihydrate Osmolarity α mOsmol/L [Osmolality, mOsmol/kg] Compound Sodium Lactate (Hartmanns) IV infusion 500mL (AHB2323) Potassium chloride 0.04%, Sodium chloride 0.6%, Sodium lactate 0.322% and Calcium chloride dihydrate 0.027% 2.7mmol/ 500mL 51.35mmol/ 500mL 14.36mmol/ 500mL 0.92mmol/ 500mL 280 [254] Compound Sodium Lactate (Hartmanns) IV infusion 1000mL (AHB2324) Potassium chloride 0.04%, Sodium chloride 0.6%, Sodium lactate 0.322% and Calcium chloride dihydrate 0.027% 5.4mmol/L 102.7mmol/L 28.72mmol/L 1.84mmol/L 280 [254] Osmolarity α is a calculated figure; whilst the figures in the brackets are Osmolality [mOsmol/kg]. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for infusion. Appearance COMPOUND SODIUM LACTATE (HARTMANNS), an intravenous (IV) infusion preparation, is a clear, colourless, sterile, non‐pyrogenic solution. COMPOUND SODIUM LACTATE (HARTMANNS) is an isotonic intravenous solution with pH of 5.0 – 7.0. 4 CLINICAL PARTICULARS 4.1 Therapeutic indications COMPOUND SODIUM LACTATE (HARTMANNS) infusion solution is indicated as a source of water and electrolytes. It is also used in patients as a source of bicarbonate in the treatment of mild to moderate metabolic acidosis associated with dehydration or associated with potassium deficiency. This solution is indicated as a method of intravenous drug delivery, if the drugs are compatible with the solution. NEW ZEALAND DATA SHEET COMPOUND SODIUM LACTATE (HARTMANNS) Data Sheet 23 May 2019 Page 2 of 13 Baxter Healthcare Ltd 4.2 Dose and method of administration To be used as directed by the physician. The dosage of COMPOUND SODIUM LACTATE (HARTMANNS) infusion solution is dep Read the complete document